Interest Income Expense - Erasca Inc (NASDAQ:ERAS) - Alpha Spread

Erasca Inc
NASDAQ:ERAS

Watchlist Manager
Erasca Inc Logo
Erasca Inc
NASDAQ:ERAS
Watchlist
Price: 2.97 USD 2.77% Market Closed
Market Cap: 810.3m USD
Have any thoughts about
Erasca Inc?
Write Note

Erasca Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Erasca Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Erasca Inc
NASDAQ:ERAS
Interest Income Expense
$16.7m
CAGR 3-Years
266%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
10%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$1.1B
CAGR 3-Years
29%
CAGR 5-Years
-12%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$3.9B
CAGR 3-Years
-61%
CAGR 5-Years
-41%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$621.3m
CAGR 3-Years
315%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$697.5m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Erasca Inc's Interest Income Expense?
Interest Income Expense
16.7m USD

Based on the financial report for Dec 31, 2023, Erasca Inc's Interest Income Expense amounts to 16.7m USD.

What is Erasca Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
266%

Over the last year, the Interest Income Expense growth was 241%. The average annual Interest Income Expense growth rates for Erasca Inc have been 266% over the past three years .

Back to Top